News & Updates

Show Multimedia Only
Tolebrutinib reduces disability accumulation in relapsing MS

Tolebrutinib reduces disability accumulation in relapsing MS

21 Apr 2025 byStephen Padilla

Treatment with tolebrutinib results in a clear reduction in disability accumulation in patients with relapsing multiple sclerosis (MS) compared with teriflunomide despite no difference in relapses, according to the findings of the GEMINI 1 and 2 trials presented at AAN 2025.

21 Apr 2025